Table 1.
Dictionary | Enriched unique terms in the KB | Status |
---|---|---|
Chemicals/compounds | ||
Chemical Entities of Biological Interest (ChEBI) [84] | 17981 | |
Toxins (T3DB) [85] | 2083 | |
Lipids (lipids maps) [86, 87] | 2852 | |
Amyloids (Human and Mouse); compiled in-house | 393 | Newly compiled |
Functional annotation | ||
Biological Process (GO) [88] | 5438 | |
Cellular Component (GO) [88] | 1125 | |
Molecular Function (GO) [88] | 1755 | |
Pathways (KEGG [89], Reactome [90], UniPathway [91], and PANTHER [92]) | 1445 | |
Diseases | ||
DOID Ontology (BioPortal)—Human Disease Ontology [93] | 3467 | |
ADO Ontology (BioPortal)—Alzheimer's disease ontology [94] | 937 | Newly compiled |
DMTO Ontology (BioPortal)—Diabetes Mellitus Treatment Ontology [95] | 1941 | Newly compiled |
HFO Ontology (BioPortal)—Heart Failure Ontology [96] | 1001 | Newly compiled |
CVDO Ontology (BioPortal)—Cardiovascular Disease Ontology [97] | 53 | Newly compiled |
HP Ontology (BioPortal)—Human Phenotype Ontology [98] | 3204 | |
UBERON Ontology (BioPortal)—Uber Anatomy Ontology [99] | 6540 | Newly compiled |
ICD9 Ontology (BioPortal)—International Classification of Diseases, Version 9 - Clinical Modification [100] | 688 | |
Drugs | ||
Drugs (DrugBank) [101] | 3918 | |
ATC Ontology (BioPortal)—Anatomical Therapeutic Chemical Classification [102] | 1991 | Newly compiled |
CSSO Ontology (BioPortal)—Clinical Signs and Symptoms Ontology | 210 | Newly compiled |
SIDER (Drug Indications and Side Effects) [103] | 3190 | |
Human | ||
Human Genes and Proteins (Entrez Gene) [104] | 21858 | |
Human Transcription Factors [105] | 1505 | |
Human Transcription Co-Factors (TcoF-DB) [105] | 384 | |
Human microRNAs (HGNC and Entrez Gene) PMEDIDs for HGNC and Entrez Gene |
1811 | Updated |
Human Long Non-Coding RNAs (HGNC) [106] | 460 | |
Mutations (tmVar) [107] | 12514 | |
Human Anatomy (in-house compiled) | 2538 | |
OMIT Ontology (BioPortal)—Ontology for MicroRNA Target [108] | 656 | Newly compiled |